Results 21 to 30 of about 365,500 (282)

Cholesterol Accumulates in Senile Plaques of Alzheimer Disease Patients and in Transgenic APPsw Mice [PDF]

open access: bronzeJournal of Neuropathology and Experimental Neurology, 2001
Takashi Mori   +10 more
semanticscholar   +2 more sources

The senile plaque: Morphological differences in APP knock‐in mice brains by fixatives

open access: yesBrain and Behavior, 2023
The morphology of senile plaques depends on the APP knock‐in mice brain fixative. Solid forms of senile plaques were detected in APP knock‐in mice after formic acid treatment with Davidson's and Bouin's fluid fixative as the brain of AD patients.
Rikuya Yoshimura   +6 more
doaj   +1 more source

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease [PDF]

open access: bronzeJournal of Neurochemistry, 2000
L. Sayre   +5 more
semanticscholar   +2 more sources

NEURITIC (SENILE) PLAQUES AND FILAMENTOUS CHANGES IN AGED RHESUS MONKEYS

open access: bronzeJournal of Neuropathology and Experimental Neurology, 1973
H. Wiśniewski, B. Ghetti, R. Terry
semanticscholar   +2 more sources

Neurofibrillary tangles and the deposition of a beta amyloid peptide with a novel N-terminal epitope in the brains of wild Tsushima leopard cats. [PDF]

open access: yesPLoS ONE, 2012
Beta amyloid (Aβ) deposits are seen in aged individuals in many of the mammalian species that possess the same Aβ amino acid sequence as humans. Conversely, neurofibrillary tangles (NFT), the other hallmark lesion of Alzheimer's disease (AD), are ...
James K Chambers   +9 more
doaj   +1 more source

Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology

open access: yesMolecular Neurodegeneration, 2021
Alzheimer’s disease (AD) is pathologically defined by the presence of fibrillar amyloid β (Aβ) peptide in extracellular senile plaques and tau filaments in intracellular neurofibrillary tangles.
M. M. Rahman, Christofer Lendel
semanticscholar   +1 more source

Microbial involvement in Alzheimer disease development and progression

open access: yesMolecular Neurodegeneration, 2020
Alzheimer disease (AD) is the most prominent form of dementia and the 5th leading cause of death in individuals over 65. AD is a complex disease stemming from genetic, environmental, and lifestyle factors.
Hannah R. Bulgart   +3 more
doaj   +1 more source

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes [PDF]

open access: yes, 2020
Background Both Alzheimer's disease (AD) and type 2 diabetes (T2D) share common pathological features including inflammation, insulin signaling alterations, or vascular damage.
Alves-Martinez, Pilar   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy